| Dr Joel Daniel Kelly, DPM | |
|
1031 W Williams St, Suite 105a, Apex, NC 27502-3955 | |
| (919) 363-3310 | |
| Not Available |
| Full Name | Dr Joel Daniel Kelly |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 18 Years |
| Location | 1031 W Williams St, Apex, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669632881 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 601 (North Carolina) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 65006321 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Carolina Hospital | Sanford, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foot And Ankle Specialists Of The Mid-atlantic Llc | 6305017633 | 147 |
News Archive
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.
The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).
New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.
A Ben-Gurion University of the Negev (BGU) study indicates that children are more likely to develop Post Traumatic Stress Disorder (PTSD) if their mother is already afflicted.
› Verified 5 days ago
| Provider Name | Doctors Making Housecalls Geriatric Medicine Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558501353 PECOS PAC ID: 5799837696 Enrollment ID: O20090806000708 |
News Archive
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.
The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).
New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.
A Ben-Gurion University of the Negev (BGU) study indicates that children are more likely to develop Post Traumatic Stress Disorder (PTSD) if their mother is already afflicted.
› Verified 5 days ago
| Provider Name | Foot And Ankle Specialists Of The Mid-atlantic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073804712 PECOS PAC ID: 6305017633 Enrollment ID: O20171228000218 |
News Archive
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.
The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).
New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.
A Ben-Gurion University of the Negev (BGU) study indicates that children are more likely to develop Post Traumatic Stress Disorder (PTSD) if their mother is already afflicted.
› Verified 5 days ago
| Provider Name | Gooden Mobile Pod Nc Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073003752 PECOS PAC ID: 2769738715 Enrollment ID: O20180703003175 |
News Archive
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.
The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).
New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.
A Ben-Gurion University of the Negev (BGU) study indicates that children are more likely to develop Post Traumatic Stress Disorder (PTSD) if their mother is already afflicted.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel Daniel Kelly, DPM 1600 E Gude Dr Ste 200, Rockville, MD 20850-1496 Ph: (301) 933-7133 | Dr Joel Daniel Kelly, DPM 1031 W Williams St, Suite 105a, Apex, NC 27502-3955 Ph: (919) 363-3310 |
News Archive
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.
The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).
New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.
A Ben-Gurion University of the Negev (BGU) study indicates that children are more likely to develop Post Traumatic Stress Disorder (PTSD) if their mother is already afflicted.
› Verified 5 days ago
Foot And Ankle Specialists Of The Mid-atlantic, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1001 Pemberton Hill Rd Ste 102, Apex, NC 27502 Phone: 919-363-3310 | |
Dr. Milton Waldo Richardson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1031 W Williams St, #105, Apex, NC 27502 Phone: 919-363-3310 Fax: 919-363-3370 | |
Podiatry Offices Of Dr. Milton Richardson Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1031 W Williams St Ste 105, Apex, NC 27502 Phone: 919-363-3310 Fax: 919-363-3370 |